» Articles » PMID: 22734465

Platelet-activating Factor and Distinct Chemokines Are Elevated in Mucosal Biopsies of Erosive Compared with Non-erosive Reflux Disease Patients and Controls

Overview
Date 2012 Jun 28
PMID 22734465
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A distinction between symptomatic non-erosive reflux disease (NERD) and erosive esophagitis (EE) patients is supported by the presence of inflammatory response in the mucosa of EE patients, leading to a damage of mucosal integrity. To explore the underlying mechanism of this difference, we assessed inflammatory mediators in mucosal biopsies from EE and NERD patients and compared them with controls.

Methods: Nineteen NERD patients, 15 EE patients, and 16 healthy subjects underwent endoscopy after a 3-week washout from PPI or H(2) antagonists. Biopsies obtained from the distal esophagus were examined by quantitative real-time polymerase chain reaction (qPCR) and multiplex enzyme-linked immunosorbent assay for selected chemokines and lyso-PAF acetyltransferase (LysoPAF-AT), the enzyme responsible for production of platelet-activating factor (PAF).

Key Results: Expression of LysoPAF-AT and multiple chemokines was significantly increased in mucosal biopsies derived from EE patients, when compared with NERD patients and healthy controls. Upregulated chemokines included interleukin 8, eotaxin-1, -2, and -3, macrophage inflammatory protein-1α (MIP-1α), and monocyte chemoattractant protein-1 (MCP-1). LysoPAF-AT and the chemokine profile in NERD patients were comparable with healthy controls.

Conclusions & Inferences: Levels of selected cytokines and Lyso-PAF AT were significantly higher in the esophageal mucosa of EE patients compared with NERD and control patients. This difference may explain the distinct inflammatory response occurring in EE patients' mucosa. In contrast, as no significant differences existed between the levels of all mediators in NERD and control subjects, an inflammatory response does not appear to play a major role in the pathogenesis of the abnormalities found in NERD patients.

Citing Articles

Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases.

Kaymak T, Hruz P, Hendrik Niess J FEBS J. 2021; 289(16):4758-4772.

PMID: 34213831 PMC: 9542113. DOI: 10.1111/febs.16103.


Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study.

Altomare A, Del Chierico F, Rocchi G, Emerenziani S, Nuglio C, Putignani L Nutrients. 2021; 13(5).

PMID: 33925672 PMC: 8170891. DOI: 10.3390/nu13051479.


The Risk of Acute Myocardial Infarction in Patients With Gastroesophageal Reflux Disease.

Eisa M, Sandhu A, Prakash R, Ganocy S, Fass R J Neurogastroenterol Motil. 2020; 26(4):471-476.

PMID: 32989184 PMC: 7547190. DOI: 10.5056/jnm19192.


Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease.

Rinsma N, Farre R, Troost F, Elizalde M, Keszthelyi D, Helyes Z Int J Mol Sci. 2017; 18(5).

PMID: 28534850 PMC: 5455000. DOI: 10.3390/ijms18051091.


Prevalence of allergic rhinitis and asthma in patients with chronic rhinosinusitis and gastroesophageal reflux disease.

Mahdavinia M, Bishehsari F, Hayat W, Codispoti C, Sarrafi S, Husain I Ann Allergy Asthma Immunol. 2016; 117(2):158-162.e1.

PMID: 27283453 PMC: 5514562. DOI: 10.1016/j.anai.2016.05.018.


References
1.
Burnstock G . Purinergic mechanosensory transduction and visceral pain. Mol Pain. 2009; 5:69. PMC: 2789721. DOI: 10.1186/1744-8069-5-69. View

2.
Snyder F . Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim Biophys Acta. 1995; 1254(3):231-49. DOI: 10.1016/0005-2760(94)00192-2. View

3.
Badewa A, Hudson C, Heiman A . Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation. Exp Biol Med (Maywood). 2002; 227(8):645-51. DOI: 10.1177/153537020222700814. View

4.
Fitzgerald R, Onwuegbusi B, Bajaj-Elliott M, Saeed I, Burnham W, Farthing M . Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut. 2002; 50(4):451-9. PMC: 1773186. DOI: 10.1136/gut.50.4.451. View

5.
Okada S, Kita H, George T, Gleich G, Leiferman K . Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. Am J Respir Cell Mol Biol. 1997; 16(4):455-63. DOI: 10.1165/ajrcmb.16.4.9115757. View